Insight

Reaching the other side of COVID 19 part I

A digital pathway

Alan White

Alan White

Advisory Managing Director, CIO Advisory, KPMG US

+1 214-840-8959

In this 1st of a 3-part series on using technology to get to the other side of COVID-19, we focus on digital pathways through the crisis.

The disruption caused by COVID-19 has led to the quick uptake of technology solutions that offer a first layer of protection to healthcare workers and the public, as they seek to get through the crisis without unnecessary exposure. As many of these technologies will become the new norm after the pandemic subsides, organizations will need to further adapt them to have a greater influence on patient outcomes, new modes of care and patient interaction, and IT and back-office operations.

In this paper, we take a look at three key technology capabilities that will be vital both during and after the pandemic –

  • Organizations using telemedicine/mobility to enhance patient access while minimizing exposure to the virus, will need to look at future enhancements that address architecture/infrastructure, scaling, bandwidth, data reliability, and privacy/security.
  • Virtualization has been effective in allowing healthcare employees with COVID-19 infections or compromised immune systems to work remotely. Looking forward, provider organizations should plan for such enhancements as application and data virtualization, multi-cloud scaling, incorporating virtual event technologies, and more stringent cybersecurity measures.
  • Data modelling and predictive forecasting are critical components of decisions related to where to focus current surveillance efforts. Both now and after this public health emergency has subsided, these technologies will allow organizations to monitor chronic disease patients at higher risk of complications, recently discharged patients for a relapse of symptoms, and contact tracing for exposed and infected individuals.

Click here for the 1st of a 3-part series on using technology to “get to the other side” of COVID-19.


 

Related content


KPMG Healthcare & Life Sciences Institute

Register to receive timely insights